circRNA basic information
circBase ID: hsa_circ_0023990
Name: hsa_circ_NOX4
Synonym: circNOX4 / Circ_0023990
Host Gene: NOX4
Genomic location(hg19): chr11:89165951-89185063:-
Genomic location(hg38): chr11:89432783-89451895:-
Subcellular localization: not tested
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0005580
MONDO name: esophageal squamous cell carcinoma
Disease details: esophageal squamous cell carcinoma / ESCC
Disease DO ID:
3748
Disease MeSH ID:
C562729; D000077277
Disease NCIt ID:
C4024
Disease ICD11 ID:
1417891145
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

ESCC tumor tissues; adjacent normal tissues; tumor tissues

Cell lines:

KYSE410; ECA109; HET-1A

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: SATB1
Associated microRNA: miR-153-3p
Biological function: Promotes ESCC cell proliferation, cell cycle progression, migration, invasion and EMT, and inhibits apoptosis; triptolide suppresses these malignant phenotypes partly by reducing circNOX4.
Molecular mechanism: circNOX4 acts as a miRNA sponge for miR-153-3p to de-repress SATB1 (ceRNA mechanism), forming a circNOX4/miR-153-3p/SATB1 axis affected by triptolide.
Biological pathway or process:

proliferation (promotes); cell cycle (promotes); apoptosis (inhibits); migration (promotes); invasion (promotes); EMT (promotes); ceRNA regulation (promotes)

Detected method:
Q
S
Validation methods:

RT-qPCR; RNA-seq; Actinomycin D / DRB Stability Assay; RNase R Treatment; Transfection; CCK8; Colony Formation Assay; Annexin V/PI Flow Cytometry; Cell Cycle Assay; Transwell Assay; Western Blot; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); In Vivo Animal Model; IHC (Immunohistochemistry); Clinical Sample Validation; Bioinformatics Analysis

Clinical significance:

-

Description:

circNOX4 is up-regulated in ESCC and promotes malignant phenotypes (proliferation, cell cycle progression, migration/invasion and EMT) while inhibiting apoptosis. Mechanistically, circNOX4 sponges miR-153-3p to upregulate SATB1; triptolide suppresses ESCC partly by downregulating circNOX4 and inhibiting the circNOX4/miR-153-3p/SATB1 axis.

Confidence score:

0.8443

Other information
Title:

Triptolide inhibits esophageal squamous cell carcinoma progression by regulating the circNOX4/miR-153-3p/SATB1 signaling pathway.

Journal: Thoracic cancer
Published: 2024
PubMed ID: 38268309
Study type:

combined biological and clinical study

Data availability: GSE131969
Code availability: -